middle.news
Clarity Shows Strong PSA Responses at 8 GBq Dose in SECuRE Trial
10:00am on Wednesday 5th of August, 2026 AEST
•
Healthcare
Read Story
Clarity Shows Strong PSA Responses at 8 GBq Dose in SECuRE Trial
10:00am on Wednesday 5th of August, 2026 AEST
Key Points
74% of patients achieved ≥25% PSA reduction at 8 GBq dose
31% of evaluable patients reached complete response or undetectable disease
Treatment generally well tolerated with mostly mild to moderate adverse events
Seven total complete responses reported across program, five at 8 GBq dose
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clarity Pharmaceuticals (ASX:CU6)
OPEN ARTICLE